{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Embolism+and+Thrombosis&page=4", "query": { "condition": "Embolism and Thrombosis", "page": 4 }, "page_size": 10 }, "pagination": { "page": 4, "page_size": 10, "total_count": 938, "total_pages": 94, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Embolism+and+Thrombosis&page=5&page_size=10", "previous_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Embolism+and+Thrombosis&page=3&page_size=10" }, "source": "remote", "last_synced_at": "2026-10-12T04:58:47.111Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT00253331", "title": "Lab Study of MQX-503 in Treatment of Raynaud's", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2", "PHASE3" ], "conditions": [ "Raynaud Disease", "Raynaud Disease Secondary to Scleroderma", "Raynaud Secondary to Other Autoimmune Disease" ], "interventions": [ { "name": "topical organogel with nitroglycerin", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "MediQuest Therapeutics", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 36, "start_date": "2004-11", "completion_date": "2005-09", "has_results": false, "last_update_posted_date": "2007-05-30", "last_synced_at": "2026-10-12T04:58:47.111Z", "location_count": 2, "location_summary": "Baltimore, Maryland • Seattle, Washington", "locations": [ { "city": "Baltimore", "state": "Maryland" }, { "city": "Seattle", "state": "Washington" } ], "official_url": "https://clinicaltrials.gov/study/NCT00253331" }, { "nct_id": "NCT06041594", "title": "Treating Pulmonary Embolism With Laguna Thrombectomy System (TRUST)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Pulmonary Embolism" ], "interventions": [ { "name": "Laguna Thrombectomy System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "Innova Vascular, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "18 Years to 85 Years" }, "enrollment_count": 107, "start_date": "2024-08-19", "completion_date": "2026-09", "has_results": false, "last_update_posted_date": "2026-07-17", "last_synced_at": "2026-10-12T04:58:47.111Z", "location_count": 16, "location_summary": "Birmingham, Alabama • Tucson, Arizona • Irvine, California + 13 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Tucson", "state": "Arizona" }, { "city": "Irvine", "state": "California" }, { "city": "Long Beach", "state": "California" }, { "city": "Mission Viejo", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT06041594" }, { "nct_id": "NCT00456001", "title": "Heparin Induced Thrombocytopenia: Pharmacoeconomics", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Heparin Induced Thrombocytopenia (HIT)" ], "interventions": [], "intervention_types": [], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 200, "start_date": "2006-07", "completion_date": "2009-01", "has_results": false, "last_update_posted_date": "2009-03-02", "last_synced_at": "2026-10-12T04:58:47.111Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT00456001" }, { "nct_id": "NCT02064439", "title": "Reduced-dosed Rivaroxaban in the Long-term Prevention of Recurrent Symptomatic VTE(Venous Thromboembolism)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Pulmonary Embolism", "Thromboembolism", "Thrombosis", "Venous Thrombosis", "Venous Thromboembolism" ], "interventions": [ { "name": "BAY 59-7939", "type": "DRUG" }, { "name": "ASA", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bayer", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 3365, "start_date": "2014-03-05", "completion_date": "2016-11-04", "has_results": true, "last_update_posted_date": "2017-12-19", "last_synced_at": "2026-10-12T04:58:47.111Z", "location_count": 24, "location_summary": "Beverly Hills, California • La Jolla, California • Ventura, California + 19 more", "locations": [ { "city": "Beverly Hills", "state": "California" }, { "city": "La Jolla", "state": "California" }, { "city": "Ventura", "state": "California" }, { "city": "Denver", "state": "Colorado" }, { "city": "Jacksonville", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT02064439" }, { "nct_id": "NCT03802630", "title": "Assessing the Efficacy and Safety of Brolucizumab Versus Aflibercept in Patients With Visual Impairment Due to Macular Edema Secondary to Branch Retinal Vein Occlusion", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Branch Retinal Vein Occlusion" ], "interventions": [ { "name": "Brolucizumab 6 mg", "type": "DRUG" }, { "name": "Aflibercept 2 mg", "type": "DRUG" }, { "name": "Sham injection", "type": "OTHER" } ], "intervention_types": [ "DRUG", "OTHER" ], "sponsor": "Novartis Pharmaceuticals", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 450, "start_date": "2019-07-02", "completion_date": "2021-07-26", "has_results": true, "last_update_posted_date": "2023-01-30", "last_synced_at": "2026-10-12T04:58:47.111Z", "location_count": 26, "location_summary": "Phoenix, Arizona • Mountain View, California • Santa Barbara, California + 21 more", "locations": [ { "city": "Phoenix", "state": "Arizona" }, { "city": "Mountain View", "state": "California" }, { "city": "Santa Barbara", "state": "California" }, { "city": "Colorado Springs", "state": "Colorado" }, { "city": "Pensacola", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT03802630" }, { "nct_id": "NCT00633893", "title": "Efficacy and Safety Study of Apixaban for Extended Treatment of Deep Vein Thrombosis or Pulmonary Embolism", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Venous Thrombosis" ], "interventions": [ { "name": "Apixaban", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Bristol-Myers Squibb", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 2711, "start_date": "2008-05", "completion_date": "2012-08", "has_results": true, "last_update_posted_date": "2013-11-25", "last_synced_at": "2026-10-12T04:58:47.111Z", "location_count": 87, "location_summary": "Birmingham, Alabama • Phoenix, Arizona • Tempe, Arizona + 82 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Tempe", "state": "Arizona" }, { "city": "Fort Smith", "state": "Arkansas" }, { "city": "Banning", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT00633893" }, { "nct_id": "NCT04393909", "title": "Improving Safety of Diagnosis and Therapy in the Inpatient Setting", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Delirium", "Confusion", "Mental Status Change", "Back Pain", "Hip Pain Chronic", "Chest Pain", "Asthma", "COPD", "Cellulitis", "Soft Tissue Infections", "Cough", "Deep Vein Thrombosis", "Pulmonary Embolism", "Venous Thromboembolism", "Dyspnea", "Electrolyte Metabolism Abnormal", "Fever", "Failure to Thrive", "Weakness", "Protein-Calorie Malnutrition", "Headache", "Neck Pain", "Hypoxia", "Pneumonia", "Sepsis", "Syncope", "Vomiting", "Diarrhea", "Leg Pain", "Abdominal Pain" ], "interventions": [ { "name": "Diagnostic Uncertainty Educational Curriculum", "type": "BEHAVIORAL" }, { "name": "Diagnostic Timeout", "type": "BEHAVIORAL" }, { "name": "Patient Diagnostic (Dx) Questionnaire", "type": "BEHAVIORAL" }, { "name": "Enhancements to Epic-integrated Quality & Safety Dashboard", "type": "BEHAVIORAL" } ], "intervention_types": [ "BEHAVIORAL" ], "sponsor": "Brigham and Women's Hospital", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 700, "start_date": "2019-07-01", "completion_date": "2021-12-30", "has_results": false, "last_update_posted_date": "2022-07-26", "last_synced_at": "2026-10-12T04:58:47.111Z", "location_count": 1, "location_summary": "Boston, Massachusetts", "locations": [ { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04393909" }, { "nct_id": "NCT00436787", "title": "Investigation Into the Therapeutic Dosage of Fondaparinux Sodium, a Medication Used to Prevent Blood Clots in Morbidly Obese Volunteers", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Venous Thrombosis", "Pulmonary Embolism" ], "interventions": [ { "name": "Fondaparinux Sodium", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "University of Pittsburgh", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 21, "start_date": "2007-02", "completion_date": "2007-12", "has_results": false, "last_update_posted_date": "2008-05-16", "last_synced_at": "2026-10-12T04:58:47.111Z", "location_count": 2, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" }, { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT00436787" }, { "nct_id": "NCT03772964", "title": "Effects of Metformin in a Non-Diabetic Patient Population", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Inflammatory Response" ], "interventions": [ { "name": "MetFORMIN Hydrochloride ER", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Brian Zuckerbraun", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "55 Years", "maximum_age": "85 Years", "sex": "ALL", "summary": "55 Years to 85 Years" }, "enrollment_count": 32, "start_date": "2019-01-22", "completion_date": "2020-03-31", "has_results": true, "last_update_posted_date": "2023-01-11", "last_synced_at": "2026-10-12T04:58:47.111Z", "location_count": 1, "location_summary": "Pittsburgh, Pennsylvania", "locations": [ { "city": "Pittsburgh", "state": "Pennsylvania" } ], "official_url": "https://clinicaltrials.gov/study/NCT03772964" }, { "nct_id": "NCT04583878", "title": "FUVID Study: Functional Characterization of Children With Chronic Venous Thromboembolic Disease", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Deep Venous Thrombosis", "Pulmonary Embolism" ], "interventions": [ { "name": "Blood draw (Visit 1)", "type": "DIAGNOSTIC_TEST" }, { "name": "Blood draw (Visits 2 and 3)", "type": "DIAGNOSTIC_TEST" } ], "intervention_types": [ "DIAGNOSTIC_TEST" ], "sponsor": "University of Texas Southwestern Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "8 Years", "maximum_age": "21 Years", "sex": "ALL", "summary": "8 Years to 21 Years" }, "enrollment_count": 115, "start_date": "2020-12-22", "completion_date": "2027-03", "has_results": false, "last_update_posted_date": "2026-06-08", "last_synced_at": "2026-10-12T04:58:47.111Z", "location_count": 14, "location_summary": "Little Rock, Arkansas • St. Petersburg, Florida • Atlanta, Georgia + 11 more", "locations": [ { "city": "Little Rock", "state": "Arkansas" }, { "city": "St. Petersburg", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Chicago", "state": "Illinois" }, { "city": "Boston", "state": "Massachusetts" } ], "official_url": "https://clinicaltrials.gov/study/NCT04583878" } ] }